Effects of a peripheral cholinesterase inhibitor on cytokine production and autonomic nervous activity in a rat model of sepsis

Cytokine

Volumn 57, Issue 2, 2012, Pages 238-244

  Setoguchi, Daisuke ^a   Yatsuki, Henry ^a   Sadahiro, Tomohito ^a   Nakamura, Masataka ^a   Hirayama, Yo ^a   Watanabe, Eizo ^a   Tateishi, Yoshihisa ^a   Oda, Shigeto ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autonomic nervous activity; Catecholamine; Cholinesterase inhibitor; Cytokine; Sepsis

Indexed keywords

ADRENALIN; CHOLINESTERASE INHIBITOR; DISTIGMINE BROMIDE; DOPAMINE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; ELECTROCARDIOGRAPHY MONITORING; HEART RATE VARIABILITY; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SEPSIS; SINGLE DRUG DOSE; SURVIVAL RATE;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; CATECHOLAMINES; CHOLINESTERASE INHIBITORS; CYTOKINES; DISEASE MODELS, ANIMAL; LIGATION; MALE; PUNCTURES; PYRIDINIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SURVIVAL ANALYSIS;

ANIMALIA; RATTUS;

EID: 84855441234     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.11.003     Document Type: Article

References (41)

1. Russell J.A. Management of sepsis. N Engl J Med 2006, 355:1699-1713.
2. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007, 117:289-296.
3. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
4. Dunser M.W., Hasibeder W.R. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 2009, 24:293-316.
5. Novotny N.M., Lahm T., Markel T.A., Crisostomo P.R., Wang M., Wang Y., et al. Beta-Blockers in sepsis: reexamining the evidence. Shock 2009, 31:113-119.
6. Huang H.H., Lee Y.H., Chan H.L., Wang Y.P., Huang C.H., Fan S.Z. Using a short-term parameter of heart rate variability to distinguish awake from isoflurane anesthetic states. Med Biol Eng Comput 2008, 46:977-984.
7. Steiner A.A., Oliveira D.L., Roberts J.L., Petersen S.R., Romanovsky A.A. Nicotine administration and withdrawal affect survival in systemic inflammation models. J Appl Physiol 2008, 105:1028-1034.
8. Wichterman K.A., Baue A.E., Chaudry I.H. Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res 1980, 29:189-201.
9. Hubbard W.J., Choudhry M., Schwacha M.G., Kerby J.D., Rue L.W., Bland K.I., et al. Cecal ligation and puncture. Shock 2005, 24(Suppl 1):52-57.
10. 14C-distigmine-bromide in healthy volunteers. Int J Clin Pharmacol Ther 1999, 37:393-403.
11. Kuwahara M., Yayou K., Ishii K., Hashimoto S., Tsubone H., Sugano S. Power spectral analysis of heart rate variability as a new method for assessing autonomic activity in the rat. J Electrocardiol 1994, 27:333-337.
12. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
13. Jeon H.K., Nohta H., Ohkura Y. High-performance liquid chromatographic determination of catecholamines and their precursor and metabolites in human urine and plasma by postcolumn derivatization involving chemical oxidation followed by fluorescence reaction. Anal Biochem 1992, 200:332-338.
14. Rosas-Ballina M., Tracey K.J. Cholinergic control of inflammation. J Intern Med 2009, 265:663-679.
15. Hofer S., Eisenbach C., Lukic I.K., Schneider L., Bode K., Brueckmann M., et al. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med 2008, 36:404-408.
16. Hashimoto T., Nagabukuro H., Doi T. Effects of the selective acetylcholinesterase inhibitor TAK-802 on the voiding behavior and bladder mass increase in rats with partial bladder outlet obstruction. J Urol 2005, 174:1137-1141.
17. Hameed A., Charles T.J. Cholinergic crisis following treatment of postoperative urinary retention with distigmine bromide. Br J Clin Pract 1994, 48:103-104.
18. Pavlov V.A., Ochani M., Gallowitsch-Puerta M., Ochani K., Huston J.M., Czura C.J., et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci USA 2006, 103:5219-5223.
19. Wu R., Dong W., Cui X., Zhou M., Simms H.H., Ravikumar T.S., et al. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 2007, 245:480-486.
20. Pavlov V.A., Ochani M., Yang L.H., Gallowitsch-Puerta M., Ochani K., Lin X., et al. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med 2007, 35:1139-1144.
21. Akselrod S., Gordon D., Ubel F.A., Shannon D.C., Berger A.C., Cohen R.J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981, 213:220-222.
22. Ori Z., Monir G., Weiss J., Sayhouni X., Singer D.H. Heart rate variability. Frequency domain analysis. Cardiol Clin 1992, 10:499-537.
23. Ahmad S., Tejuja A., Newman K.D., Zarychanski R., Seely A.J. Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection. Crit Care 2009, 13:232.
24. Pancoto J.A., Correa P.B., Oliveira-Pelegrin G.R., Rocha M.J. Autonomic dysfunction in experimental sepsis induced by cecal ligation and puncture. Auton Neurosci 2008, 138:57-63.
25. Fairchild K.D., Saucerman J.J., Raynor L.L., Sivak J.A., Xiao Y., Lake D.E., et al. Endotoxin depresses heart rate variability in mice: cytokine and steroid effects. Am J Physiol Regul Integr Comp Physiol 2009, 297:R1019-R1027.
26. Pontet J., Contreras P., Curbelo A., Medina J., Noveri S., Bentancourt S., et al. Heart rate variability as early marker of multiple organ dysfunction syndrome in septic patients. J Crit Care 2003, 18:156-163.
27. Tateishi Y., Oda S., Nakamura M., Watanabe K., Kuwaki T., Moriguchi T., et al. Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patients. Shock 2007, 28:549-553.
28. Chen W.L., Chen J.H., Huang C.C., Kuo C.D., Huang C.I., Lee L.S. Heart rate variability measures as predictors of in-hospital mortality in ED patients with sepsis. Am J Emerg Med 2008, 26:395-401.
29. Papaioannou V.E., Dragoumanis C., Theodorou V., Gargaretas C., Pneumatikos I. Relation of heart rate variability to serum levels of C-reactive protein, interleukin 6, and 10 in patients with sepsis and septic shock. J Crit Care 2009, 24:625e1-625e7.
30. Burykin A., Peck T., Krejci V., Vannucci A., Kangrga I., Buchman T.G. Toward optimal display of physiologic status in critical care: I. Recreating bedside displays from archived physiologic data. J Crit Care 2011, 26:105e1-105e9.
31. Peter C., Schmidt K., Hofer S., Stephan M., Martin E., Weigand M.A., et al. Effects of physostigmine on microcirculatory alterations during experimental endotoxemia. Shock 2010, 33:405-411.
32. Akselrod S., Eliash S., Oz O., Cohen S. Hemodynamic regulation in SHR: investigation by spectral analysis. Am J Physiol 1987, 253:H176-H183.
33. Uechi M., Asai K., Osaka M., Smith A., Sato N., Wagner T.E., et al. Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gsalpha. Circ Res 1998, 82:416-423.
34. Huang J., Wang Y., Jiang D., Zhou J., Huang X. The sympathetic-vagal balance against endotoxemia. J Neural Transm 2010, 117:729-735.
35. Landmann R. Beta-adrenergic receptors in human leukocyte subpopulations. Eur J Clin Invest 1992, 22(Suppl 1):30-36.
36. Schedlowski M., Hosch W., Oberbeck R., Benschop R.J., Jacobs R., Raab H.R., et al. Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms. J Immunol 1996, 156:93-99.
37. Bergmann M., Sautner T. Immunomodulatory effects of vasoactive catecholamines. Wien Klin Wochenschr 2002, 114:752-761.
38. Muthu K., Deng J., Gamelli R., Shankar R., Jones S.B. Adrenergic modulation of cytokine release in bone marrow progenitor-derived macrophage following polymicrobial sepsis. J Neuroimmunol 2005, 158:50-57.
39. Horn N.A., Anastase D.M., Hecker K.E., Baumert J.H., Robitzsch T., Rossaint R. Epinephrine enhances platelet-neutrophil adhesion in whole blood in vitro. Anesth Analg 2005, 100:520-526.
40. Werdan K., Schmidt H., Ebelt H., Zorn-Pauly K., Koidl B., Hoke R.S., et al. Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol 2009, 87:266-274.
41. Huston J.M., Gallowitsch-Puerta M., Ochani M., Ochani K., Yuan R., Rosas-Ballina M., et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007, 35:2762-2768.